NHS framework for Macitentan tablets; suppliers contact team.
NHS England is establishing a national framework for the supply of Macitentan tablets, a pharmaceutical product used for treating pulmonary arterial hypertension. The framework is open to suppliers who currently market or plan to introduce this molecule. Interested parties should contact the MPSC New Market Developments Team via email. The notice signals a forthcoming procurement exercise for this specific drug.
Open the official notice for the full requirements, documents and submission details.
View original noticeOr start a response in qlows